
Pre-Launch: Early brand lifecycle management
Our client wanted to prepare effectively for a Rare Disease launch across the major European markets. Their aim was to shape subsequent patient finding activities and referral pathways for patient diagnosis & treatment in specialist centres.
The Republic M team were engaged to profile and identify high value audiences across each market based on consulting time with the at-risk patient profile.
RM Proven Outcomes:
Indentification of the most valuable
10-31%
of the patient finding audience.